Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications
International Journal of Molecular Sciences · 21.05.2026 · 27 (10) · 4630
DOI: 10.3390/ijms27104630 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2026. Verfasst von Dimitris Liapopoulos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biopathological Laboratory, General and Oncology Hospital "Agioi Anargyroi", National and Kapodistrian University of Athens, Timiou Stavrou 14, 145 6…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, T-Lymphocytes, Regulatory, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide, increasingly driven by metabolic dysfunction-associated steatotic liver disease alongside viral and alcohol-related cirrhosis. The tolerogenic immune environment of the liver enables tumor immune escape, with regulatory T cells (Tregs) playing a central role. This review synthesizes human-focused evidence (tissues, blood, clinical cohorts, and single-cell/spatial studies) through September 2025 to define how Tregs are recruited, maintained, and functionally deployed in HCC. Across datasets, intratumoral effector-like Tregs (eTregs) expressing ICOS, CTLA-4, CCR8, and CD39/CD73 accumulate within tumors and co-localize with exhausted cytotoxic PD-1hi CD8+ T cells and suppressive myeloid cells. Recruitment is driven mainly by CCL20–CCR6 and CCL22/CCL17–CCR4 signaling, while CCR8 marks highly suppressive tumor-resident Tregs. Their persistence is supported by TGF-β, IL-10, IL-35, adenosine signaling, IL-2 sequestration, and metabolic adaptation. Spatial biomarkers, including ICOS+/CCR8+ eTreg density and CD8:Treg ratios, associate with prognosis and emerging immunotherapy responses. Etiology further shapes immune architecture: HBV-related HCC often forms Treg-exhausted T-cell niches around viral antigens, whereas MASLD/MASH promotes stromal and metabolic barriers that may reduce PD-(L)1 efficacy. Current treatments (PD-(L)1 blockade with anti-VEGF or CTLA-4, and some TKIs) intersect with Treg biology, while emerging strategies targeting CCR8, CCR4, ICOS, or the adenosine pathway aim to selectively disrupt intratumoral eTreg networks. This review underscores that an etiology-aware, spatial-biomarker framework may guide the integration of selective Treg targeting with PD-(L)1-based therapies in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biopathological Laboratory, General and Oncology Hospital "Agioi Anargyroi", National and Kapodistrian University of Athens, Timiou Stavrou 14, 145 64 Kifisia, Greece.
- Biopathological Laboratory, Athens Medical Group, Psychiko Clinic, Antersen 1, 115 25 Psychiko, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 115 27 Athens, Greece.
- University Clinic of Internal Medicine, General and Oncology Hospital "Agioi Anargyroi", National and Kapodistrian University of Athens, Timiou Stavrou 14, 145 64 Kifisia, Greece.
- Institute of Molecular Medicine and Biomedical Research, 115 27 Athens, Greece.
- Second Department of Internal Medicine-GI-Liver Unit, General Hospital 'Hippokratio', Medical School, National and Kapodistrian University of Athens, Vasilissis Sofias 114, 115 27 Athens, Greece.
ORCID-Profile: Panagiotis Sarantis, Ioanna A Anastasiou, Ioannis Elefsiniotis, Michalis V Karamouzis
Zitieren
APA
Liapopoulos, D., Sarantis, P., Zogas, G., Trifylli, E. M., Bousou, T. E., Kamitaki, K., Anastasiou, I. A., Kokkali, S., Mavromatis, S., Koustas, E., Elefsiniotis, I., Biniari, T., & Karamouzis, M. V. (2026). Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications. International Journal of Molecular Sciences, 27(10), 4630. https://doi.org/10.3390/ijms27104630
Vancouver
Liapopoulos D, Sarantis P, Zogas G, Trifylli EM, Bousou TE, Kamitaki K, et al. Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications. International Journal of Molecular Sciences. 2026;27(10):4630. doi:10.3390/ijms27104630
BibTeX
@article{Liapopoulos2026,
author = {Liapopoulos, Dimitris and Sarantis, Panagiotis and Zogas, Georgios and Trifylli, Eleni-Myrto and Bousou, Thaleia-Eleftheria and Kamitaki, Konstantina and Anastasiou, Ioanna A and Kokkali, Stefania and Mavromatis, Sotiris and Koustas, Evangelos and Elefsiniotis, Ioannis and Biniari, Theodora and Karamouzis, Michalis V},
title = {Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4630},
doi = {10.3390/ijms27104630}
}
EUVIMED